NCT00519623 - Transdermal Basal Insulin Patch Study in Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions

Type 1 Diabetes

Interventions

OTHER

PassPort(R) Transdermal Insulin Delivery System

The PassPort(R) Transdermal Insulin Delivery System is a drug-device combination product used to create micropores in the skin to enable transdermal delivery of insulin.

Trial Locations (1)

30313

Altea Therapeutics Clinical Research Center, 387 Technology Circle, NW, Suite 100, Atlanta